Combinati
Palo Alto
About Combinati
Combinati is develops the Next Generation PCR for Every Lab. Their bleeding-edge technology enables doctors and researchers to detect & track critical biomarkers
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.8M
- Funding stage: Seed
- Last round: Seed (Sep 2019)
- Website: combinati.com
- Phone: 415-890-6885
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/combinati-107087 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.